Company Kariana Resources Inc Canadian Securities Exchange
Equities
KAA
CA4856462029
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Business Summary
Sales per Business
CAD in Million | 2023 | Weight | Delta |
---|---|---|---|
Psychedelic Medicines
100.0
%
| 1 | 100.0 % | - |
Sales per region
CAD in Million | 2023 | Weight | Delta |
---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Shacker
CEO | Chief Executive Officer | 34 | - |
Director of Finance/CFO | 46 | 18/08/20 | |
Santiago Ferro
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/21 |
Phil Gurat
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 46 | 18/08/20 | |
Robert Hancock
CHM | Chairman | 75 | 05/01/21 |
Patrick Morris
BRD | Director/Board Member | 56 | 26/01/21 |
Joel Shacker
CEO | Chief Executive Officer | 34 | - |
Santiago Ferro
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,097,332 | 46,955,947 ( 99.70 %) | 0 | 99.70 % |
Company contact information
Core One Labs, Inc.
595 Burrard Street Suite 3123
V7X 1J1, Vancouver
+888-452-6731
http://www.core1labs.comSector
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |
- Stock Market
- Equities
- COOL Stock
- KAA Stock
- Company Kariana Resources Inc